期刊文献+

神经型尼古丁乙酰胆碱受体α7亚单位基因多态性与散发性Alzheimer病的关联分析

Correlative analysis between nellronal nicotinic acetylcholine receptor α7 subunit gene polymorphism and sporadic Alzheimer's disease
暂未订购
导出
摘要 目的探讨散发性Alzheimer病(SAD)与神经型尼古丁乙酰胆碱受体α7亚单位(CHRNA7)基因多态性的关系。方法用聚合酶链式反应温度梯度凝胶电(PCRTGGE)和DNA测序技术分析16例SAD患者及16名正常人CHRNA7基因全部10个外显子及其两侧的部分内含子序列和内含子4的部分基因序列。结果在CHRNA7基因上发现2个新的多态性位点;内含子3区的133418G/C突变,两组相比差异无显著性(χ2=4.571,P>0.05);内含子7上的117643+GTG三碱基插入突变,两组相比差异无显著性(χ2=1.032,P>0.05)。结论在CHRNA7基因上发现的2个新的多态性位点与SAD的发病无显著相关性。 Objective To investigate the correlation between nellronal nicotinic acetylcholine receptor α7 subnnit (CHRNA7) gene polymorphism and sporadic Alzheimer's disease (SAD). Methods CHRNA7 gene was screened by PCR-TGGE in 16 patients with SAD and 16 healthy people as normal control. Genomic DNA including all exons and 4 shot pieces of intron 4 were amplified using PCR and GC-clapped primers. Abnormal bands in TGGE were sequenced. Results Two new polymorphic sites were found in CHRNA7 gene. There was no significant difference of 133418 G/C mutation in intron 3 between the two groups (χ^2= 4.571, P 〉0. 05 ). Also no significant difference of 3bp insertion mutation (117643 + GTG) was observed in intron 7 between SAD and control groups ( χ^2 = 1. 032, P 〉0. 05 ). Conclusion Two new polymorphic sites were found in CHRNA7 gene. There were not associated in pathsgenesis of SAD.
出处 《临床神经病学杂志》 CAS 北大核心 2006年第4期241-243,共3页 Journal of Clinical Neurology
基金 国家自然科学基金项目(30450045) 贵州省省长基金(2001003) 贵州省科技厅国际合作项目(200211008)
关键词 ALZHEIMER病 尼古丁乙酰胆碱受体α7亚单位 基因多态性 Alzheimer's disease nicotinic acetylcholine receptor α7 subunit gene polymorphism
  • 相关文献

参考文献10

  • 1Braak E,Strotkamp B,Braak H.Parvalbumin-immunoreactive structures in the hippocampus of the human adult[J].Cell Tissue Res,1991,264:33.
  • 2丁新生.重视Alzheimer病的诊治[J].临床神经病学杂志,2005,18(4):241-243. 被引量:17
  • 3官志忠.阿尔茨海默病的病理学及生物膜结构与受体改变机制[J].中华病理学杂志,2003,32(1):69-71. 被引量:14
  • 4American Psychiatric Association.DSM-Ⅳ:Diagnosis and Statistical Manual of Mental Disorders 4th ed[M].Washington D.C.:American Psychiatric Press,1994.92~94.
  • 5Lloyd GK,Williams M.Neuronal nicotinic acetylcholine receptors as novel drug targets[J].J Pharmacol Exp Ther,2000,292:461.
  • 6齐艳飞,单可人,徐鹰,赵明祥,刘芳,李光荣,张婷,李毅,官志忠,任锡麟.神经型尼古丁胆碱能受体α4亚单位基因外显子3基因多态性与散发性Alzheimer病的关系[J].临床神经病学杂志,2006,19(3):161-163. 被引量:3
  • 7Chini B,Raimond E,Elgoyhen AB,et al.Molecular cloning and chromosomal localization of the human alpha 7-nicotinic receptor subunit gene (CHRNA7)[J].Genomics,1994,19:379.
  • 8Hogg RC,Raggenbass M,Bertrand D.Nicotinic acetylcholine receptors:from structure to brain function[J].Rev Physiol Biochem Pharmacol,2003,147:1.
  • 9Nagele RG,D'Andrea MR,Anderson WJ,et al.Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease[J].Neuroscience,2002,110:199.
  • 10Wang HY,Li W,Benedetti NJ,et al.Alpha 7 nicotinic acetylcholine receptors mediate beta-amyloid peptide-induced tau protein phosphorylation[J].J Biol Chem,2003,278:31547.

二级参考文献30

  • 1丁新生.重视Alzheimer病的诊治[J].临床神经病学杂志,2005,18(4):241-243. 被引量:17
  • 2Grundman M, Petersen RC, Ferris SH, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials[J]. Arch Neurol, 2004,61:59.
  • 3Borroni B,Rozzini L, Broglio L, et al.Platelet amyloid precursor protein abnormalities in mild congnitive impairment predict conversion to dementia of Alzheimer type[J]. Arch Neurol,2003,60:1740.
  • 4Emre M,Hanagasi HA. Evidence-based pharmacological treatment of dementia[J]. Eur J Neuro,2000, 7: 247.
  • 5Mackenzis IR,Moons DG. Nonsteroid anti-in-flammatory drug use and Alzheimer-type pathology in aging[J].Neurology, 1998,50: 986.
  • 6Tierney MC, Fisher RH, Lewis AJ,et al. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease : A clinic-pathologic study of 57 cases[J]. Neurology, 1988, 38:359.
  • 7Blacker D, A lbertM S, Bassett SS, et al. Reliability and validity of NINCDS-ADRDA criteria for Alzheimar's disease[J] . Arch Neuro, 1994, 51: 1198.
  • 8Morris JC, Heyman A, Mohs RC, et al. The consortium to a registry for Alzheimer's disease part Ⅰ. Clinical and neuropsychological assessment of Alzheimer's disease[J]. Neurology, 1989, 39:1159.
  • 9Palmer K, Bckman L, Winblad B, et al. Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study[J]. BMJ,2003,326:245.
  • 10Chui H. Reaching a diagnosis of a dementia subtype. In: Qizilbash N, ed. Evidence-based dementia practice[M]. Oxford, England: Blackwell Science, 2002.106.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部